Bullboard - Stock Discussion Forum Diagnos Inc V.ADK

Alternate Symbol(s): DGNOF

Healthcare Medical Devices

DIAGNOS Inc. is a Canadian company, which is engaged in early detection of critical health problems based on its FLAIRE artificial intelligence (AI) platform. FLAIRE allows for modifying and developing of applications, such as Computer Assisted Retina Analysis (CARA). CARA’s image enhancement algorithms provide sharper, clearer and easier-to-analyze retinal images. CARA is a tool for real-time... see more

Add To Watchlist

TSXV:ADK - Post Discussion

Diagnos Inc > DIAGNOS Extension of its Contract with Novo Nordisk

View:

Post by Betteryear2 on Apr 26, 2022 9:53am

DIAGNOS Extension of its Contract with Novo Nordisk

BROSSARD, Quebec, April 26, 2022 (GLOBE NEWSWIRE) -- Diagnos Inc. (“DIAGNOS”, the “Corporation” or “we”) (TSX Venture: ADK) (OTCQB: DGNOF), a leader in early detection of critical health issues through the use of its FLAIRE platform based on Artificial Intelligence (AI), is pleased to announce the extension of its contract for the follow-up of Diabetic patients under treatment with drugs included in its therapeutic portfolio.

DIAGNOS Announces the Extension of its Contract with Novo Nordisk for the Follow-up of Diabetic Patients Under Treatment with Drugs Included in its Therapeutic Portfolio

133